SCHLAGWORTE: Antibody-Drug Conjugates
Promatix expands target space for ADCs with bispecific platform
Promatix Biosciences presented new data at American Association for Cancer Research (AACR) Annual Meeting 2026, addressing a key bottleneck in the development of antibody–drug...

